| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 119.42B | 120.64B | 117.90B | 98.17B | 84.50B | 80.23B |
| Gross Profit | 21.28B | 21.05B | 18.31B | 11.72B | 12.62B | 15.10B |
| EBITDA | 13.03B | 13.40B | 12.63B | 6.87B | 8.32B | 10.62B |
| Net Income | 3.58B | 3.96B | 5.04B | 2.11B | 2.10B | 2.70B |
Balance Sheet | ||||||
| Total Assets | 137.58B | 138.40B | 137.73B | 126.13B | 115.63B | 115.62B |
| Cash, Cash Equivalents and Short-Term Investments | 49.65B | 49.92B | 45.36B | 42.70B | 38.98B | 38.42B |
| Total Debt | 19.58B | 20.16B | 20.20B | 26.30B | 21.93B | 20.76B |
| Total Liabilities | 49.20B | 46.67B | 50.22B | 50.59B | 43.16B | 44.40B |
| Stockholders Equity | 84.84B | 87.94B | 84.54B | 72.91B | 68.63B | 67.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.61B | 10.54B | 226.00M | 370.00M | 1.88B |
| Operating Cash Flow | 0.00 | 9.24B | 14.88B | 5.45B | 4.16B | 6.38B |
| Investing Cash Flow | 0.00 | -4.34B | -5.16B | -4.68B | -4.97B | -3.06B |
| Financing Cash Flow | 0.00 | -2.88B | -9.40B | 1.28B | -897.00M | 6.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥517.74B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
75 Outperform | ¥6.62B | 5.89 | ― | 2.64% | 2.28% | 41.72% | |
73 Outperform | ¥150.98B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
70 Outperform | $561.16B | 6.51 | 4.89% | 2.59% | -0.26% | 129.15% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.02T | 6.03 | 9.11% | 1.60% | 10.53% | -2.52% | |
58 Neutral | ¥3.99B | 10.35 | ― | 3.03% | 4.17% | -693.96% |